Pharmacia & Upjohn

Overview

Pharmacia & Upjohn was a global pharmaceutical company formed through the merger of the Swedish company Pharmacia AB and the American company The Upjohn Company in 1995. The merger combined the strengths of both companies in the pharmaceutical industry, creating a significant player in the global market.

History

Pharmacia & Upjohn was established in 1995 when Pharmacia AB, a leading pharmaceutical company in Sweden, merged with The Upjohn Company, an American pharmaceutical firm known for its innovative drug development. The merger aimed to leverage the research and development capabilities of both companies to enhance their product offerings and expand their global reach.

Pharmacia AB

Pharmacia AB was founded in 1911 in Stockholm, Sweden. It was known for its development of biotechnology products and pharmaceuticals, including the production of insulin and other critical medications. Pharmacia AB had a strong presence in Europe and was recognized for its contributions to the field of biotechnology.

The Upjohn Company

The Upjohn Company was established in 1886 in Kalamazoo, Michigan, USA. It gained a reputation for its innovative approach to drug development and was known for producing a wide range of pharmaceuticals, including antibiotics and hormone therapies. The company was a pioneer in the development of sustained-release medications.

Merger and Operations

The merger of Pharmacia AB and The Upjohn Company created a new entity with a diverse portfolio of pharmaceutical products. Pharmacia & Upjohn focused on several therapeutic areas, including oncology, endocrinology, and infectious diseases. The company invested heavily in research and development to bring new and innovative drugs to market.

Global Presence

Pharmacia & Upjohn had a significant global presence, with operations in over 60 countries. The company maintained research facilities and manufacturing plants worldwide, allowing it to serve a diverse customer base and meet the growing demand for pharmaceutical products.

Acquisition by Pfizer

In 2003, Pharmacia & Upjohn was acquired by Pfizer, one of the largest pharmaceutical companies in the world. The acquisition was part of Pfizer's strategy to expand its product portfolio and strengthen its position in the global pharmaceutical market. Following the acquisition, Pharmacia & Upjohn's operations were integrated into Pfizer's existing business structure.

Legacy

Pharmacia & Upjohn's legacy continues through its contributions to the pharmaceutical industry, particularly in the areas of biotechnology and innovative drug development. The company's commitment to research and development has had a lasting impact on the availability of effective treatments for various medical conditions.

Related Pages

• Pharmacia AB
• The Upjohn Company
• Pfizer
• Biotechnology
• Pharmaceutical industry